| Gauge | Colour | Flow Rate | Indication |
|---|---|---|---|
| 14G | Orange | ~270 mL/min | Rapid fluid resuscitation / major trauma |
| 16G | Grey | ~180 mL/min | Surgery, blood transfusion, fast fluids |
| 18G | Green | ~96 mL/min | Standard IV fluids, blood products |
| 20G | Pink | ~54 mL/min | IV medications, routine access |
| 22G | Blue | ~31 mL/min | Paediatrics, fragile veins, elderly |
| 24G | Yellow | ~13 mL/min | Neonates, very small/fragile veins |
- Confirm clinical indication, check patient ID (2 identifiers), review request form for correct tubes.
- Position patient comfortably. Apply tourniquet to distend veins. Identify suitable antecubital or forearm vein.
- Clean with chlorhexidine 2%/alcohol. Allow to dry. Insert needle bevel-up at 20–30° angle.
- Attach vacuum tube. Fill to line. Release tourniquet BEFORE withdrawing needle to prevent haematoma.
- Withdraw needle, apply pressure with gauze, label tubes at bedside before leaving patient.
- Document procedure, transport to laboratory promptly (within recommended stability windows).
| Order | Cap Colour | Additive | Use |
|---|---|---|---|
| 1st | Blood Culture Bottles | SPS | Microbiology — aerobic first, then anaerobic |
| 2nd | Blue | Sodium Citrate (3.2%) | Coagulation (PT, APTT, INR) |
| 3rd | Gold / Red | Clot activator/gel | Biochemistry (LFTs, TFTs, U&E, lipids) |
| 4th | Green | Lithium Heparin | U&E, stat chemistry |
| 5th | Lavender / EDTA | EDTA | FBC, HbA1c, blood film |
| 6th | Grey | Fluoride Oxalate | Glucose, lactate |
| 7th | Black | Sodium Citrate (3.8%) | ESR |
- Verify prescriber's order — legible, signed, dated. Query incomplete or unclear orders before proceeding.
- Check patient ID using at least 2 identifiers (name + DOB, or name + MRN). Match against wristband.
- Review allergies — check wristband AND medication chart. If allergy present, do NOT administer and notify prescriber.
- Perform medication calculation independently or with qualified witness for high-alert medications.
- Administer medication. Remain present to confirm ingestion. Do not pre-pour medications.
- Document immediately after administration — never before. Record time, dose, route, your signature.
- Monitor for therapeutic effect and adverse reactions per drug profile.
- Stop enteral feed 30 minutes before administration (check per drug guidelines). Flush tube with 30 mL sterile water.
- Confirm tube position: aspirate gastric contents, test with CE-marked pH paper. Record pH. If pH ≥5.5 — do NOT give medication, escalate.
- Prepare medications individually. Crush only immediate-release (IR) solid-dose tablets. Disperse in 10–15 mL water.
- Administer each drug separately, flushing with 10 mL water between drugs.
- Flush with final 30 mL sterile water after all medications given. Re-attach feed if prescribed.
- Document time, drugs given, tube position check result, flush volumes.
Air bubbles: Remove air bubbles by tapping pen/syringe upright before injection.
| Site | Max Volume | Landmark | Notes |
|---|---|---|---|
| Ventrogluteal | 4 mL | Greater trochanter + ASIS triangle | Preferred site — fewest major blood vessels/nerves |
| Vastus Lateralis | 5 mL | Middle third of lateral thigh | Preferred for infants; good for self-injection |
| Deltoid | 1 mL | 3 finger-widths below acromion process | Vaccines, small volumes only |
| Dorsogluteal | 4 mL | Upper outer quadrant | Not recommended — risk of sciatic nerve injury |
Aspiration: Not recommended for vaccines (WHO/ACIP guidance). May be appropriate for specific drugs per local protocol — follow your facility policy.
- Check drug, dose, diluent and concentration against BNF/facility formulary. Use manufacturer's SmPC for reconstitution details.
- Reconstitute powder vials with correct diluent volume. Swirl (do not shake) until fully dissolved.
- Further dilute to prescribed concentration in appropriate bag (NS 0.9%, D5W, etc.). Label bag with drug, concentration, date, time, prepared by.
- Program infusion pump. Double-check rate calculation: Rate (mL/hr) = Volume (mL) ÷ Time (hr).
- Prime IV line, remove air bubbles. Connect to patient's IV access and commence infusion.
- Monitor patient during infusion — check for extravasation, allergic reaction, haemodynamic changes.
| Route | Normal Range | Notes |
|---|---|---|
| Oral | 36.1–37.2°C | Place probe under tongue. Avoid hot/cold drinks 15 min prior. |
| Axillary | 35.9–36.7°C | Less accurate; add ~0.5°C for core estimate. |
| Rectal | 36.6–37.9°C | Gold standard (0.5°C above oral). Use only if clinically indicated. |
| Tympanic | 36.1–37.5°C | Pull pinna back and up (adults); straight back (children <3yrs). Correct probe position is critical. |
| Score | Risk | Response |
|---|---|---|
| 0–4 | Low | Routine monitoring. Minimum 12-hourly NEWS2. |
| 5–6 or any single 3 | Medium | Urgent review by registered nurse + consider medical review. Continuous monitoring. |
| 7+ | High | Emergency response. Immediate medical review. Consider HDU/ICU transfer. |
| Scale | Population | Range | Notes |
|---|---|---|---|
| NRS (Numeric) | Adults, verbal | 0–10 | 0=no pain, 10=worst imaginable. Simple, widely used. |
| VAS (Visual Analogue) | Adults, literate | 0–100 mm | Patient marks 10 cm line. Measure with ruler. |
| Wong-Baker FACES | Children ≥3 yrs | 0–10 | 6 face images from happy to crying. Child points to face. |
| CPOT | ICU non-verbal | 0–8 | 4 domains: facial expression, body movements, muscle tension, ventilator compliance. |
| FLACC | Children & non-verbal adults | 0–10 | 0–3 mild, 4–6 moderate, 7–10 severe pain. |
- Wash patient's hands with soap and water, dry thoroughly. Warm if peripherally cool.
- Use automated lancet device. Select lateral pad of fingertip (avoid central pulp — more painful). Rotate sites.
- Discard first drop of blood (may be diluted with interstitial fluid). Use second drop.
- Apply blood to test strip edge — fill completely. Read result per meter display. Note meter calibration status.
- Apply pressure. Record result, time, and clinical context in patient notes and medication chart.
| BGL (mmol/L) | Status | Action |
|---|---|---|
| <4.0 | Hypoglycaemia | Treat per hypoglycaemia protocol. 15g fast-acting carbs if conscious. Recheck 15 min. |
| 4.0–7.8 | Target (fasting) | Routine monitoring. |
| 7.9–11.0 | Above target | Review insulin/diet. Notify diabetes team if persistent. |
| >11.0 (or HI) | Hyperglycaemia | Confirm with lab if symptomatic. Assess for DKA/HHS. Medical review. |
| Wound Type | Dressing Choice | Notes |
|---|---|---|
| Clean, dry, healing | Low-adherent / vapour-permeable film | Promote moist healing environment |
| Heavily exuding | Foam / Alginate | High-absorbency; change when saturated |
| Sloughy / necrotic | Hydrogel / Hydrocolloid | Rehydrate and facilitate autolytic debridement |
| Infected wound | Silver-impregnated / Iodine cadexomer | Anti-microbial; culture before applying |
| Granulating wound | Non-adherent foam or soft silicone | Protect fragile granulation tissue |
| Cavity wound | Alginate rope / Foam cavity | Light packing — do NOT over-pack |
| Step | Action |
|---|---|
| 1 | Palm to palm — rub together |
| 2 | Right over left, interlaced fingers (back of hands) |
| 3 | Palm to palm, fingers interlaced |
| 4 | Backs of fingers to opposing palms (interlocked) |
| 5 | Rotational rubbing of right thumb in left palm; repeat opposite |
| 6 | Rotational rubbing of clasped fingers in right palm; repeat opposite |
- Entry Level RN: Direct supervision required. Core clinical skills, medication safety, documentation.
- Intermediate RN: Independent practice. Evidence-based care, patient education, team collaboration.
- Advanced RN: Leadership, preceptorship, clinical decision-making, quality improvement participation.
Annual competency verification required for license renewal. Portfolio-based evidence. Minimum CPD hours per licensing cycle.
Nursing scope of practice defined by registration level (RN, Senior RN, Clinical Nurse Specialist). Competency assessed at registration and for renewals.
| Domain | Description |
|---|---|
| Professional & Ethical Practice | Accountability, confidentiality, scope of practice, professional conduct |
| Patient-Centred Care | Assessment, planning, intervention, evaluation, patient safety |
| Communication & Collaboration | Handover (ISBAR), teamwork, escalation, documentation standards |
| Leadership & Management | Delegation, resource management, change management, supervision |
| Education & Development | CPD, clinical teaching, evidence-based practice, competency maintenance |
| Level | Description | Portfolio Evidence |
|---|---|---|
| Supervised Practice | Assessor present, directly observing every attempt | Assessor signature, date, comments on each attempt |
| Supported Practice | Assessor available but not directly observing every step | Dated entries, reflective accounts, spot checks |
| Unsupervised Practice | Competent to practise independently per scope | Completed competency sign-off, annual review date |
| Teaching Others | Assessed to teach and supervise others in this skill | Teaching records, trainee evaluations, NMC/assessor record |
- I — Identity (who are you, who is the patient)
- S — Situation (what is the problem right now)
- B — Background (history, diagnosis, current treatment)
- A — Assessment (your clinical assessment of the situation)
- R — Recommendation (what action do you want/need)
- M — Measure (length × width × depth in cm)
- E — Exudate (colour, volume, consistency)
- A — Appearance (tissue type — granulation, slough, necrotic)
- S — Suffering (pain score)
- U — Undermining (palpate wound edges)
- R — Re-evaluate (response to treatment)
- E — Edge (attached vs. non-attached, EPT)
Q1. When performing peripheral IV cannulation, at what angle should the cannula be inserted?
Q2. What is the minimum volume of blood that should be inoculated per blood culture bottle in an adult?
Q3. In venepuncture using the VACUETTE system, which tube is drawn SECOND after blood culture bottles?
Q4. A patient has NEWS2: RR=22, SpO2=94%, on room air, BP=100, HR=105, alert, temp=38.4°C. Which risk category applies?
Q5. In ANTT, what are "key parts"?
Q6. For NG tube medication administration, what pH result confirms gastric tube placement?
Q7. Which IM injection site is considered the PREFERRED site for adults due to fewest major structures?
Q8. During insulin pen injection, how many units should be primed before each injection?
Q9. What does the "U" stand for in the MEASURE wound assessment framework?
Q10. A patient's blood glucose reads 3.6 mmol/L and they are conscious and able to swallow. What is the FIRST action?